Columbia Asset Management
Source: SEC Form 13F · as of Mar 2026Columbia Asset Management holds 13 biotech & pharma companies tracked by BioSniper, totaling $60.0M in value as of Mar 2026 (SEC Form 13F).
Companies held
13
Total value held
$60.0M
| Company | Shares | Value |
|---|---|---|
| MRKMerck & Co., Inc. | 111,663 | $13.4M |
| JNJJOHNSON & JOHNSON | 54,270 | $13.3M |
| AMGNAMGEN INC | 22,420 | $7.9M |
| LLYELI LILLY & Co | 8,431 | $7.8M |
| ABBVAbbVie Inc. | 35,329 | $7.7M |
| PFEPFIZER INC | 194,260 | $5.5M |
| VRTXVERTEX PHARMACEUTICALS INC / MA | 2,889 | $1.3M |
| PMPhilip Morris International Inc | 5,455 | $902K |
| AZNASTRAZENECA PLC | 4,189 | $826K |
| ABTABBOTT LABORATORIES | 4,591 | $471K |
| GILDGILEAD SCIENCES, INC. | 3,085 | $430K |
| BMYBRISTOL MYERS SQUIBB CO | 5,425 | $329K |
| GSKGSK plc American Depositary Shares (Each representing two Ordinary Shares) | 5,333 | $294K |
13F holdings reflect long positions in U.S.-listed securities as reported to the SEC. Values are point-in-time for the most recent reported quarter.